Skip to content
Lower risk Drug recall · FDA · Published February 7, 2019

ACP Nimble Recalls Mometasone Furoate Cream Due to Labeling Error

ACP Nimble Buyer recalls Mometasone Furoate Cream 0.1% due to an NDC typographical error on the label. Check your lot numbers and expiration dates.

🇺🇸 FDA recall #D-0514-2019DrugACP Nimble Buyer ›
Take action

Contact the company

Recalling firmACP Nimble Buyer, Inc.111 Coolidge St · South Plainfield, NJ 07080-3801
✎ GovInfoNow plain-language explainer

ACP Nimble Buyer, Inc. is recalling Mometasone Furoate Cream, 0.1%, 45 g tubes because of a labeling issue. The product contains a typographical error in the National Drug Code (NDC). This recall affects specific lots distributed nationwide. Read more at govinfonow.com/recall/39204-acp-nimble-recalls-mometasone-furoate-cream-due-to-labeling-error.

Source Summary by GovInfoNow · govinfonow.com/recall/39204-acp-nimble-recalls-mometasone-furoate-cream-due-to-labeling-error · Updated October 11, 2026 · FDA enforcement record: FDA #D-0514-2019

Cite this page

“ACP Nimble Recalls Mometasone Furoate Cream Due to Labeling Error.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/39204-acp-nimble-recalls-mometasone-furoate-cream-due-to-labeling-error. Based on FDA recall #D-0514-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0514-2019%22&limit=1).

The Food and Drug Administration announced on Feb. 7, 2019, that ACP Nimble Buyer, Inc. voluntarily recalled Mometasone Furoate Cream due to a labeling error involving an NDC typographical mistake. The agency issued recall number D-0514-2019 for the Class III drug.

How to tell if you have it

  • Brand: ACP Nimble Buyer
  • Product: Mometasone Furoate Cream, 0.1%, 45 g tube
  • NDC: 0713-0726-37
  • Lot codes: 1009431 (Exp. 08/2020), 1009507 (Exp. 08/2020), 1009886 (Exp. 09/2020)
  • Manufacturer: G&W Laboratories, Inc.
  • Units affected: 58,176

The hazard

The recall addresses a labeling hazard where Mometasone Furoate Cream contains an NDC typographical error. The FDA classified the issue as Class III, indicating it is not likely to cause adverse health consequences.

Context

GovInfoNow's records show other recent recalls of similar products include ACME Dynarex Antiseptic Towelettes (2026-01-20) and Leading Pharma Furosemide 80mg (2026-03-20). Additional recent actions involve Nivagen Zinc Oxide Ointment recalled on 2025-10-31 for CGMP deviations.

How to tell if you have this one

Look for Mometasone Furoate Cream, 0.1%, 45 g tube, Rx Only, manufactured by G&W Laboratories, Inc. Check for NDC 0713-0726-37 and Lot numbers 1009431 (Exp. 08/2020), 1009507 (Exp. 08/2020), or 1009886 (Exp. 09/2020).

  • Brand
    ACP Nimble Buyer
  • Category
    Drug

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 13 months after the firm started it.

1. Firm started the recall: Feb 7, 201912. FDA classified it Class III: Feb 20, 201923. Published in FDA’s Enforcement Report: Feb 27, 201934. FDA terminated the recall: Mar 23, 2020420192020
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the expiration date of the recalled product?

Lots 1009431 and 1009507 expire in August 2020, and lot 1009886 expires in September 2020.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0514-2019 (February 7, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0514-2019 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA